+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency



Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency



Journal of Lipid Research 56(10): 1926-1935



Niemann-Pick type C (NPC) is a progressive neurodegenerative disease characterized by lysosomal/endosomal accumulation of unesterified cholesterol and glycolipids. Recent studies have shown that plasma cholestane-3β,5α,6β-triol (CT) and 7-ketocholesterol (7-KC) could be potential biomarkers for the diagnosis of NPC patients. We aimed to know the sensitivity and specificity of these biomarkers for the diagnosis of NPC compared with other diseases that can potentially lead to oxysterol alterations. We studied 107 controls and 122 patients including 16 with NPC, 3 with lysosomal acid lipase (LAL) deficiency, 8 with other lysosomal diseases, 5 with galactosemia, 11 with cerebrotendinous xanthomatosis (CTX), 3 with Smith-Lemli-Opitz, 14 with peroxisomal biogenesis disorders, 19 with unspecific hepatic diseases, 13 with familial hypercholesterolemia, and 30 with neurological involvement and no evidence of an inherited metabolic disease. CT and 7-KC were analyzed by HPLC-ESI-MS/MS as mono-dimethylglycine derivatives. Levels of 7-KC were high in most of the studied diseases, whereas those of CT were only high in NPC, LAL, and CTX patients. Consequently, although CT is a sensitive biomarker of NPC disease, including those cases with doubtful filipin staining, it is not specific. 7-KC is a very unspecific biomarker.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057401996

Download citation: RISBibTeXText

PMID: 26239048

DOI: 10.1194/jlr.M060343


Related references

Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype. Jimd Reports 23(): 17-26, 2015

Determination of serum cholestane-3β,5α,6β-triol by gas chromatography-mass spectrometry for identification of Niemann-Pick type C (NPC) disease. Journal of Steroid Biochemistry and Molecular Biology (): -, 2016

Selective screening of Niemann-Pick type C Brazilian patients by cholestane-3β,5α,6β-triol and chitotriosidase measurements followed by filipin staining and NPC1/NPC2 gene analysis. Clinica Chimica Acta; International Journal of Clinical Chemistry 459: 57-62, 2016

Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics. Journal of Medicinal Chemistry 53(14): 5281-5289, 2010

Lysosomal phospho lipases in mutant human fibroblasts deficiency of phospho lipase c in niemann pick disease. American Journal of Human Genetics 31(6): 37A, 1979

The oxidation of 5p-cholestane-3a, 7a, 12a, 26-tetranol to 5p-cholestane-3a, 7a, 12a-triol-26-oic acid via 5p-cholestane-3a, 7a, 12a-triol-26-al by rat liver. Biochem Biophys Acta 117(1): 266-268, 1966

Chemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors. Biochimica et Biophysica Acta 1791(12): 1155-1165, 2010

Niemann-Pick type C2 deficiency impairs autophagy-lysosomal activity, mitochondrial function, and TLR signaling in adipocytes. Journal of Lipid Research 57(9): 1644-1658, 2016

Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments. Journal of Virology 83(16): 7982-7995, 2009

Niemann-Pick Type C disease: characterizing lipid levels in patients with variant lysosomal cholesterol storage. Journal of Lipid Research 52(4): 813-825, 2011

Niemann-Pick C1 functions independently of Niemann-Pick C2 in the initial stage of retrograde transport of membrane-impermeable lysosomal cargo. Journal of Biological Chemistry 285(7): 4983-4994, 2010

Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann-Pick C1 disease - Lysosomal storage disorders caused by defects of non-lysosomal proteins. Biochimica et Biophysica Acta 1793(4): 710-725, 2009

Lysosomal pH-inducible supramolecular dissociation of polyrotaxanes possessing acid-labile iN -triphenylmethyl end groups and their therapeutic potential for Niemann-Pick type C disease. Science and Technology of Advanced Materials 17(1): 361-374, 2016

Molecular basis of acid sphingomyelinase deficiency in a patient with Niemann-Pick disease type A. Biochemical and Biophysical Research Communications 179(3): 1187-1191, 1991